MedPath

Genetic and clinical study of adrenal tumor causing high blood pressure

Not Applicable
Conditions
Health Condition 1: null- Pheochromocytoma/Paraganglioma
Registration Number
CTRI/2013/02/003391
Lead Sponsor
Diamond Jubilee Society Trust
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
200
Inclusion Criteria

Histologically proven cases of PHEO/PG

Exclusion Criteria

None

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
This study is expected to unravel the incidence of germline mutations in clinically screened pheochromocytoma/paraganglioma patients and their penetrance in the Indian population.Timepoint: 5 years
Secondary Outcome Measures
NameTimeMethod
The correlation between the clinical and genetic profiles seeks to optimize genetic counseling, thus furthering patient careTimepoint: 1 year
© Copyright 2025. All Rights Reserved by MedPath